Compare AGCO & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGCO | TFX |
|---|---|---|
| Founded | 1990 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 5.3B |
| IPO Year | 1994 | 1994 |
| Metric | AGCO | TFX |
|---|---|---|
| Price | $113.25 | $130.99 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $119.09 | ★ $138.75 |
| AVG Volume (30 Days) | 684.4K | ★ 887.3K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.05% | 1.02% |
| EPS Growth | ★ 271.35 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $10,082,000,000.00 | $1,992,713,000.00 |
| Revenue This Year | $6.52 | $15.97 |
| Revenue Next Year | $5.56 | $5.15 |
| P/E Ratio | $149.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $95.96 | $100.18 |
| 52 Week High | $143.78 | $139.67 |
| Indicator | AGCO | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 42.88 | 56.43 |
| Support Level | $110.62 | $117.57 |
| Resistance Level | $117.59 | $135.64 |
| Average True Range (ATR) | 3.90 | 4.51 |
| MACD | -0.43 | -0.25 |
| Stochastic Oscillator | 2.38 | 70.20 |
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.